Wellington Management Group
WX

Wellington Management Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Wellington Management Group’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-5,303,724
Closed -$229M – 2336
2015
Q3 		$229M Sell
5,303,724
-1,826,988
-26% -$77.1M 0.06% 277
2015
Q2 		$301M Sell
7,130,712
-907,784
-11% -$38.3M 0.08% 241
2015
Q1 		$312M Buy
8,038,496
+2,743,072
+52% +$106M 0.08% 249
2014
Q4 		$178M Buy
5,295,424
+242,342
+5% +$8.56M 0.05% 365
2014
Q3 		$177M Sell
5,053,082
-329,502
-6% -$11.3M 0.05% 366
2014
Q2 		$177M Buy
5,382,584
+2,415,928
+81% +$82.7M 0.05% 395
2014
Q1 		$109M Sell
2,966,656
-231,216
-7% -$8.49M 0.03% 492
2013
Q4 		$123M Sell
3,197,872
-235,338
-7% -$7.43M 0.04% 462
2013
Q3 		$94.1M Sell
3,433,210
-338,392
-9% -$8.02M 0.03% 515
2013
Q2 		$79.2M Buy
+3,771,602
New +$73.6M 0.03% 542

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Wellington Management Group's WX Position: Q4 2015 in Review

Wellington Management Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 5,303,724 shares — an estimated $229M sold.

Wellington Management Group first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $312M in Q1 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Wellington Management Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Wellington Management Group sold 5,303,724 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $229M.
  • Wellington Management Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Wellington Management Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $312M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Wellington Management Group's 13F filing for Q4 2015, filed 12 Feb 2016.